1. Tempus AI to participate in Morgan Stanley's healthcare conference. 2. CEO Eric Lefkofsky and CFO Jim Rogers will host a fireside chat. 3. Tempus focuses on AI for precision medicine and patient care. 4. Company aims to personalize treatments using extensive multimodal data. 5. Live webcast of the conversation will be available online.
Participation in major healthcare conference increases visibility. Historical examples show conference participation can boost stock prices.
Participation in a well-regarded conference highlights Tempus's commitment to innovation and enhances investor confidence.
Immediate interest from investors due to conference attendance can lead to short-term price fluctuations.
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in Morgan Stanley's 23rd Annual Global Healthcare Conference. The conference will take place September 8-10 in New York City. Eric Lefkofsky, Founder and CEO of Tempus, and Jim Rogers, Chief Financial Officer, will participate in a fireside chat on September 8 from 1:05 to 1:40 p.m. EST.
A live audio webcast of the conversation will be available here.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250903424068/en/
Hanah Heintzelman
hanah.heintzelman@tempus.com